WO2026057051 - RNAI AGENT FOR INHIBITING LPA GENE EXPRESSION IN CELLS, PREPARATION METHOD THEREFOR AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/057051
Publication Date
19.03.2026
International Application No.
PCT/CN2025/121067
International Filing Date
12.09.2025
Title **
[English]
RNAI AGENT FOR INHIBITING LPA GENE EXPRESSION IN CELLS, PREPARATION METHOD THEREFOR AND USE THEREOF
[French]
AGENT ARNI INHIBANT L'EXPRESSION DU GÈNE LPA DANS LES CELLULES, PROCÉDÉ DE PRÉPARATION ET UTILISATION ASSOCIÉS
[Chinese]
一种用于抑制细胞中LPA基因表达的RNAi剂、其制备方法及用途
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
JIANG, Wenjuan
ZHANG, Weiji
LI, Jiani
XIAO, Ying
LU, Yinsuo
WU, Junjun
XIONG, Xiaolin
WU, Jianli
Priority Data
202411296687.8
14.09.2024
CN
202411628965.5
13.11.2024
CN
202510435858.9
08.04.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2007 | |
| EPO | Filing, Examination, Granting | 13554 | |
| Japan | Filing, Examination, Granting | 2263 | |
| South Korea | Filing, Examination, Granting | 2387 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
24,951
Contact Us
Abstract[English]
Provided are an RNAi agent for inhibiting the LPA gene expression in cells, a preparation method therefor and the use thereof, and further provided is the use of the RNAi agent and a pharmaceutical composition containing the RNAi agent in the prevention or treatment of Lp(a)-related diseases.[French]
La présente invention concerne un agent ARNi inhibant l'expression du gène LPA dans les cellules, un procédé de préparation afférent et son utilisation, ainsi que l'utilisation de l'agent ARNi et d'une composition pharmaceutique contenant l'agent ARNi pour la prévention ou le traitement de maladies liées à la Lp(a).[Chinese]
提供一种用于抑制细胞中LPA基因表达的RNAi剂、其制备方法及用途，还提供RNAi剂以及包含所述RNAi剂的药物组合物用于预防或治疗与Lp(a)相关疾病中的用途。